【摘 要】
：
The enforcement of collaboration between governments and local NGOs is too often seen as a dogmatic position pushed by excited Northern activists and advocated by weak Northern governments or UN agenc
【机 构】
：
Former Vice-Chair of the Global Fund to Fight AIDS, Tuberculosis, and Malaria(GFATM)
【出 处】
：
2006中国天津世界艾滋病日科技会议
论文部分内容阅读
The enforcement of collaboration between governments and local NGOs is too often seen as a dogmatic position pushed by excited Northern activists and advocated by weak Northern governments or UN agencies.There has been little simple and clear explanations about the necessity to pursue such a partnership for the sake of the AIDS fight.In fact it is obvious that the need for cross generational programs will require people living with HIV themselves,parents,teachers,vulnerable groups,and all sort of leaders,including religious ones,to be involved both in the prevention aspects of the fight and also in life-long treatment compliance.The best ways for any individual to join its efforts is through non governmental organisations.The very beginning of comprehensive.response to the epidemic set the tone for a new deal between patients and doctors.
其他文献
The HIV-1 reverse transcriptase (RT) has been a successful target for chemotherapeutic intervention.However,new drugs are urgently needed for systemic or for topical use as a microbicide due to the ev
NIFEVIROC,a small molecular compound,is a proprietary drug candidate which is developed by TARGETDRUG and holds great promise in inhibiting HIV-1 replication in infected paitents.Preclinical studies s
The continuing emergence of resistant strains of the human immunodeficiency virus type 1 (HIV-1) makes the search for new anti-HIV-1 agents very urgent One of the most attractive target for selective
Until the end of 2005,twenty-seven drags targeted to the human immunodeficiency virus (HIV) have been approved by the U.S.Food and Drug Administration (FDA).Although great progress has been made in th
Human Immunodeficiency virus (HIV) is composed of two viral types:HIV-1 and HIV-2.HIV-1 is pandemic.Sequence analysis of HIV-1 has allowed to classify this virus into three groups:M (major),O (outlier
Combination therapy with reverse transcriptase and protease inhibitors is the most common current treatment of HIV-1 infection.Despite the success of this therapy,it has adverse effects and drug resis
We identified,characterized and defined the molecular mechanism of two novel inhibitors of HIV-1.These small molecules are effective against multiple steps of the viral life cycle.They inhibit HIV-1 a
In confronting the pandemic,the most obvious strategy is to make treatment as widely available as possible.Beyond treatment,however,the focus should be on prevention.Large inflows of new funding prese
Drug resistance in HIV-1 protease can also occasionally confer a change in the substrate specificity.Through the use of computational techniques,a relationship can be determined between the substrate
HIV/AIDS can be considered as a kind of infectious disease mainly related to the behavior in general though it can be transmitted by unscreened blood transfusion or mother to infant transmission.The b